2) brain ischemic tolerance
脑缺血耐受
1.
Brain-derived erythropoietin and its effects on brain ischemic tolerance;
脑源性EPO及其脑缺血耐受作用
2.
Objective To examine whether spreading depression(SD) precondition can induce brain ischemic tolerance.
目的验证扩散性抑制(SD)可诱导脑缺血耐受。
3.
Aim: To explore roles of metabotropic glutamate receptor1/5(mGluR1/5)in the induction of brain ischemic tolerance(BIT) induced by cerebral ischemic preconditioning(CIP), influences of mGluR1/5 ligand (s) 4 carboxy 3 hydroxy phenylglycine ((s) 4C3HPG) on the induction of BIT and expression of glial fibrillary acidic protein(GFAP) in the hippocampus were observed.
目的 :观察侧脑室注射代谢型谷氨酸受体 1 /5亚型 (mGluR1 /5)配体 (s) 4C3HPG对海马脑缺血耐受 (BIT)诱导的影响 ,以探讨mGluR1 /5在BIT诱导中的作用。
3) cerebral ischemic tolerance
脑缺血耐受
1.
Role of opioid receptors in cerebral ischemic tolerance induced by electroacupuncture preconditioning in rats;
阿片受体在电针预处理诱导大鼠脑缺血耐受效应中的作用
2.
Objective To observe the effect of focal cerebral ischemic pretreatment on the expression of interleukin-17(IL-17) and to investigate the relationship between IL-17 and cerebral ischemic tolerance in rats.
目的观察局灶性脑缺血预处理对IL-17表达的影响,探讨IL-17与脑缺血耐受的关系。
3.
Objective: To observe the cerebral ischemic tolerance induced by PDS preconditioning and its effect on expression of GFAP.
目的:观察三七二醇皂甙(PDS)预处理诱导脑缺血耐受及对胶质纤维酸性蛋白(GFAP)表达水平的影响。
6) ischemic tolerance
缺血耐受
1.
Expression of hypoxia inducible factor-1α and erythropoietin in the rat model of brain ischemic tolerance;
脑缺血耐受大鼠缺氧诱导因子-1α和促红细胞生成素的表达
2.
Expression and correlation between erythropoietin mRNA and hypoxia inducible factor-1α mRNA in rats with brain ischemic tolerance;
脑缺血耐受大鼠促红细胞生成素和缺氧诱导因子-1α的表达及其相关性
3.
A study on ischemic preconditioning as induction of cerebral ischemic tolerance in rat;
脑缺血预处理诱导大鼠脑缺血耐受的研究
补充资料：短暂性脑缺血发作
短暂性脑缺血发作
transient ischemic attack,TIA
急性脑血管病之一。指一时性脑缺血引起的一种局限性脑功能丧失，通常在24小时内完全缓解，不遗留重要神经功能缺陷。主要病因是脑动脉粥样硬化，亦可见于各种原因的动脉炎和心脏病。颈内动脉系统的脑缺血发作以病灶对侧的单瘫或偏瘫为常见，尤以上肢和面部为重，可伴有失语及精神症状。椎-基底动脉系统的脑缺血发作常见症状有眩晕、复视、构音障碍、吞咽困难、共济失调、单侧或双侧肢体瘫痪或感觉障碍等，至少两种以上症状共同出现。大脑后动脉供血不足可出现皮质盲，对侧同向偏盲。防治短暂性脑缺血发作，应针对每个人的病因，对发作次数多，考虑为微栓塞所致者，可慎重地选择抗凝治疗。主要病灶在颈部的动脉、颈内动脉颅内段或限于大脑中动脉主干者，可结合病人的具体情况考虑外科治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条